Heart failure & cardiomyopathiesCohort study

“Baseline Characteristics and Utilization of Medical Therapies in Acute Hospitalized and Chronic Heart Failure Patients Enrolled in Global Registries and Surveys Programme-Heart Failure (GRASP-HF): Differences Between ICARe-HF and Non-ICARe-HF Centres”

Eur J Heart FailPublished

  • prospective, multicentre, international observational study

Authors' conclusion

Participation in the ICARe-HF programme was associated with more comprehensive implementation of contemporary GDMT, particularly in HFrEF. The association with in-hospital mortality was attenuated after adjustment and should be considered exploratory.

Study context

Population
Acute hospitalized and chronic heart failure patients enrolled in GRASP-HF, stratified by ICARe-HF centre participation63.3% chronic HF (CHF), 36.7% AHF, 51.3% from ICARe-HF participating centres
Participants
10,936 participants
Exposure
patients managed in centres participating or not participating in the ICARe-HF programme

Main finding

As reported in the abstract

Baseline characteristics
  • Patients from ICARe-HF participating centres were older, more comorbid but with less severe congestion

Observational data: associations, not effects.

Further findings

OutcomeICARe-HF centresNon-ICARe-HF centresOR (95% CI)
Quadruple therapy implementation in HFrEF · after adjustment1.73 (1.17–2.55)
CHF47%40%
AHF discharge27%24%
In-hospital mortality · after multivariable adjustment; association attenuated · should be considered exploratorycrude 2.3%crude 5.5%0.87 (0.48–1.56)

Guideline-directed-medical-therapy (GDMT) utilization in CHF and AHF

ICARe-HF centres demonstrated greater GDMT utilization, particularly angiotensin receptor-neprilysin inhibitors and sodium-glucose-cotransporter-2 inhibitors

Target doses

Target doses remained suboptimal, particularly after AHF

Original publication

“Baseline Characteristics and Utilization of Medical Therapies in Acute Hospitalized and Chronic Heart Failure Patients Enrolled in GRASP-HF: Differences Between ICARe-HF and Non-ICARe-HF Centres”. Eur J Heart Fail. Published 13 October 2026. doi:10.1093/ejhf/xuag317

Summarised from the published abstract; every number is checked against it